Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase.

Noguchi Y, Yasuda Y, Tashiro M, Kataoka T, Kitamura Y, Kandeel M, Kitade Y.

Parasitol Int. 2013 Aug;62(4):368-71. doi: 10.1016/j.parint.2013.03.009.

PMID:
23583697
2.

Carbocyclic thymidine derivatives efficiently inhibit Plasmodium falciparum thymidylate kinase (PfTMK).

Kato A, Yasuda Y, Kitamura Y, Kandeel M, Kitade Y.

Parasitol Int. 2012 Sep;61(3):501-3. doi: 10.1016/j.parint.2012.03.001.

PMID:
22425904
3.

Potential application of thymidylate kinase in nucleoside analogue activation in Plasmodium falciparum.

Cui H, Ruiz-Pérez LM, González-Pacanowska D, Gilbert IH.

Bioorg Med Chem. 2010 Oct 15;18(20):7302-9. doi: 10.1016/j.bmc.2010.07.006.

PMID:
20833052
4.

Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery.

Kandeel M, Ando T, Kitamura Y, Abdel-Aziz M, Kitade Y.

Parasitology. 2009 Jan;136(1):11-25. doi: 10.1017/S0031182008005301.

PMID:
19126267
5.

The substrate binding preferences of Plasmodium thymidylate kinase.

Kandeel M, Kitade Y.

Biol Pharm Bull. 2011;34(1):173-6.

6.

Thymidylate kinase: the lost chemotherapeutic target.

Kandeel M, Kato A, Kitamura Y, Kitade Y.

Nucleic Acids Symp Ser (Oxf). 2009;(53):283-4. doi: 10.1093/nass/nrp142.

PMID:
19749371
7.

Synthesis and evaluation of α-thymidine analogues as novel antimalarials.

Cui H, Carrero-Lérida J, Silva AP, Whittingham JL, Brannigan JA, Ruiz-Pérez LM, Read KD, Wilson KS, González-Pacanowska D, Gilbert IH.

J Med Chem. 2012 Dec 27;55(24):10948-57. doi: 10.1021/jm301328h.

8.

Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.

Hocková D, Keough DT, Janeba Z, Wang TH, de Jersey J, Guddat LW.

J Med Chem. 2012 Jul 12;55(13):6209-23. doi: 10.1021/jm300662d.

PMID:
22725979
9.

Synthesis of carbocyclic nucleosides and their SAH hydrolase inhibitory activities.

Kitade Y, Kozaki A, Miwa T, Nakanishi M, Yatome C.

Nucleic Acids Symp Ser. 2000;(44):111-2.

PMID:
12903293
10.

Synthesis of carbocyclic and acyclic nucleosides possessing 2-fluoroadenine derivatives and their inhibitory activities against Plasmodium falciparum SAH hydrolase.

Kitade Y, Kojima H, Zulfiqur F, Yabe S, Yamagiwa D, Ito Y, Nakanishi M, Ueno Y, Kim HS, Wataya Y.

Nucleic Acids Res Suppl. 2003;(3):5-6.

PMID:
14510352
11.

Synthesis of 2-modified aristeromycins and their analogs as potent inhibitors against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase.

Ando T, Iwata M, Zulfiqar F, Miyamoto T, Nakanishi M, Kitade Y.

Bioorg Med Chem. 2008 Apr 1;16(7):3809-15. doi: 10.1016/j.bmc.2008.01.046.

PMID:
18295495
12.

First report on exploring structural requirements of α and β thymidine analogs for PfTMPK inhibitory activity using in silico studies.

Ojha PK, Roy K.

Biosystems. 2013 Sep;113(3):177-95. doi: 10.1016/j.biosystems.2013.07.005.

PMID:
23850534
13.

Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.

Nguyen C, Ruda GF, Schipani A, Kasinathan G, Leal I, Musso-Buendia A, Kaiser M, Brun R, Ruiz-Pérez LM, Sahlberg BL, Johansson NG, Gonzalez-Pacanowska D, Gilbert IH.

J Med Chem. 2006 Jul 13;49(14):4183-95.

PMID:
16821778
14.

L-nucleoside analogues as potential antimalarials that selectively target Plasmodium falciparum adenosine deaminase.

Brown DM, Netting AG, Chun BK, Choi Y, Chu CK, Gero AM.

Nucleosides Nucleotides. 1999 Nov-Dec;18(11-12):2521-32.

PMID:
10639753
15.

Purine and pyrimidine pathways as targets in Plasmodium falciparum.

Cassera MB, Zhang Y, Hazleton KZ, Schramm VL.

Curr Top Med Chem. 2011;11(16):2103-15. Review.

16.

Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases.

Kaiser MM, Hocková D, Wang TH, Dračínský M, Poštová-Slavětínská L, Procházková E, Edstein MD, Chavchich M, Keough DT, Guddat LW, Janeba Z.

ChemMedChem. 2015 Oct;10(10):1707-23. doi: 10.1002/cmdc.201500322.

PMID:
26368337
17.

Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.

Banerjee T, Sharma SK, Kapoor N, Dwivedi V, Surolia N, Surolia A.

IUBMB Life. 2011 Dec;63(12):1101-10. doi: 10.1002/iub.553.

18.

Synthesis and antimalarial activity of new atovaquone derivatives.

El Hage S, Ane M, Stigliani JL, Marjorie M, Vial H, Baziard-Mouysset G, Payard M.

Eur J Med Chem. 2009 Nov;44(11):4778-82. doi: 10.1016/j.ejmech.2009.07.021.

PMID:
19747753
19.

Synthesis and antimalarial activity of dihydroperoxides and tetraoxanes conjugated with bis(benzyl)acetone derivatives.

Franco LL, de Almeida MV, E Silva LF, Vieira PP, Pohlit AM, Valle MS.

Chem Biol Drug Des. 2012 May;79(5):790-7. doi: 10.1111/j.1747-0285.2012.01345.x.

PMID:
22284812
20.

Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity.

Ohkanda J, Lockman JW, Yokoyama K, Gelb MH, Croft SL, Kendrick H, Harrell MI, Feagin JE, Blaskovich MA, Sebti SM, Hamilton AD.

Bioorg Med Chem Lett. 2001 Mar 26;11(6):761-4.

PMID:
11277514

Supplemental Content

Support Center